MAZE vs UNH · rev $20.0M vs P/E 30, rev $112.03B
Maze Therapeutics, Inc. Common Stock (MAZE) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
Latest reported MAZE revenue for 2026-06-30 was $20.0M. Net income was -$68.9M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. MAZE currently screens at market cap $525.3M.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
MAZE currently screens at market cap $525.3M. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the MAZE and UNH stock pages for the full models.
Not investment advice.